Exagen Inc. - Common Stock (NQ:XGN)

7.760 +0.290 (+3.88%)

Delayed Quote Updated: 11:14 AM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Exagen Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Exagen Announces Appointment of John Aballi as CEO

October 17, 2022

From Exagen Inc.

Via GlobeNewswire

Exagen Announces Appointment of Andrew L. Concoff MD, FACR, CAQSM, as Chief Innovation Officer

October 04, 2022

From Exagen Inc.

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Monday ↗

September 26, 2022

Monday saw 825 companies set new 52-week lows.

Via Benzinga

Earnings Scheduled For May 11, 2022 ↗

May 11, 2022

Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.

Via Benzinga

Exagen: Q4 Earnings Insights ↗

March 23, 2022

Exagen (NASDAQ:XGN) reported its Q4 earnings results on Tuesday, March 22, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Exagen...

Via Benzinga

Exagen: Q3 Earnings Insights ↗

November 10, 2021

Exagen (NASDAQ:XGN) reported its Q3 earnings results on Wednesday, November 10, 2021 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Exagen...

Via Benzinga

Short Interest Sector Focus: Healthcare Sector ↗

September 26, 2022

As of the close of business on Friday, 9/23, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector...

Via Benzinga

Short Interest Sector Focus: Healthcare Sector ↗

August 30, 2022

As of the close of business on Monday, 8/29, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector...

Via Benzinga

Exagen's Return On Capital Employed Overview ↗

August 24, 2022

Exagen (NASDAQ:XGN) brought in sales totaling $8.96 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 29.57%, resulting in a loss of $13.31 million.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 05, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

May 16, 2022

On Monday, 198 companies reached new 52-week lows.

Via Benzinga

Exagen: Q2 Earnings Insights ↗

August 09, 2021

Shares of Exagen (NASDAQ:XGN) fell after the company reported Q2 results. Quarterly Results Earnings per share were down 40.74% over the past year to ($0.38), which beat the...

Via Benzinga

Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday ↗

August 08, 2022

Gainers

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Why Cooper-Standard Is Trading Higher By 70%, Here Are 81 Stocks Moving In Friday's Mid-Day Session ↗

August 05, 2022

Gainers Assure Holdings Corp. (NASDAQ: IONM) shares jumped 88.8% to $3.9650 after jumping around 104% on Thursday.

Via Benzinga

Exagen: Q1 Earnings Insights ↗

May 11, 2022

Exagen (NASDAQ:XGN) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Exagen beat estimated earnings by 1.64%,...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

April 18, 2022

On Monday, 466 companies hit new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...

Via Benzinga

Exagen's Return On Capital Employed Overview ↗

March 23, 2022

According to Benzinga Pro data, during Q4, Exagen (NASDAQ:XGN) posted sales of $12.69 million. Earnings were up 1.76%, but Exagen still reported an overall loss of $7.05 million....

Via Benzinga

Earnings Scheduled For March 22, 2022 ↗

March 22, 2022

Companies Reporting Before The Bell • GDS Holdings (NASDAQ:GDS) is projected to report quarterly loss at $0.18 per share on revenue of $338.69 million. • HUYA (...

Via Benzinga

A Preview Of Exagen's Earnings ↗

March 21, 2022

Exagen (NASDAQ:XGN) is set to give its latest quarterly earnings report on Tuesday, 2022-03-22. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

March 02, 2022

Wednesday's session saw 107 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: Citigroup (NYSE:C) was the largest company by...

Via Benzinga

Exagen Inc. (XGN) Q3 2021 Earnings Call Transcript ↗

November 11, 2021

XGN earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Looking Into Exagen's Return On Capital Employed ↗

September 14, 2021

Exagen (NASDAQ:XGN) brought in sales totaling $12.77 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 3.14%, resulting in a loss of $5.74...

Via Benzinga

85 Biggest Movers From Yesterday ↗

August 11, 2021

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX...

Via Benzinga

Exagen Stock Gains As Q2 Financials Surpass Street Expectations ↗

August 10, 2021

Exagen Inc (NASDAQ: XGN) shares are moving after the Company's Q2 2021 revenue increased 43% Y/Y to $12.8 million due to increased testing volumes, beating the...

Via Benzinga

54 Stocks Moving In Tuesday's Mid-Day Session ↗

August 10, 2021

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy...

Via Benzinga

Exagen Inc. (XGN) Q2 2021 Earnings Call Transcript ↗

August 10, 2021

XGN earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Earnings Scheduled For August 9, 2021 ↗

August 09, 2021

Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •...

Via Benzinga

Return On Capital Employed Overview: Exagen ↗

June 18, 2021

In Q1, Exagen (NASDAQ:XGN) posted sales of $10.59 million. Earnings were up 101.63%, but Exagen still reported an overall loss of $5.57 million. In Q4, Exagen brought in $12.67...

Via Benzinga

Exagen: Return On Capital Employed Insights ↗

June 03, 2021

During Q1, Exagen's (NASDAQ:XGN) reported sales totaled $10.59 million. Despite a 101.63% in earnings, the company posted a loss of $5.57 million. Exagen collected $12.67 million...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.